OBODENCE™ and XBRYK™ recommended for approval by the European Medicines Agency for all indications referencing Prolia and Xgeva, respectivelyINCHEON, South...
Vancouver, British Columbia--(Newsfile Corp. - November 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or...
Marlborough, Massachusetts--(Newsfile Corp. - November 14, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company exploring new...
Conference Call Scheduled for Friday, November 15 at 11:30 AM ESTNorthvale, New Jersey--(Newsfile Corp. - November 14, 2024) - Elite...
Report Outlines the Realities of Asthma Care in the United States and the Policy and Clinical Interventions that May Provide...
Top biopharma company selects the next generation of CRM for life sciences as its commercial foundation for future expansion and launches...
PHILADELPHIA, Nov. 14, 2024 /PRNewswire/ -- Health Union, the leading digital health company building online communities that empower people to live...
Pioneering Health: Innovations in Korea's Biotech Sector SEOUL, South Korea and NEW YORK, Nov. 14, 2024 /PRNewswire/ -- The Korea...
BOZEMAN, Mont., Nov. 14, 2024 /PRNewswire/ -- Bumrungrad International Hospital, a leading global healthcare provider based in Bangkok, Thailand, and...
LONDON, Nov. 14, 2024 /PRNewswire/ -- Coronado Research announced today that Alexander McCormick has been appointed as Chief Commercial Officer. Alexander...
RADNOR, Pa., Nov. 14, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to...
Synchronizing sales and marketing improves outcomes, yet 65% of field engagements are not PLEASANTON, Calif., Nov. 14, 2024 /PRNewswire/ --...
Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system,...
World's First-Ever Study Tracking Biodistribution of DehydraTECH GLP-1 Molecules KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / November 14, 2024 / Lexaria...
Target enrollment in the chronic cohort of our Phase 1b/2a clinical trial of NVG-291 in individuals with spinal cord injury...
This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding...
-- Transformative Financing worth up to $275 million from Top-Tier Institutional Healthcare Investors -- -- Advancement of IkT-001Pro into a...
BOSTON and LEUVEN, Belgium, Nov. 14, 2024 /PRNewswire/ -- Why this news will impact the lives of people affected by Alzheimer's...
PRINCETON, N.J., Nov. 13, 2024 /PRNewswire/ -- EDETEK, Inc., a leading global provider of specialized software and services for the...
HILLSIDE, NJ / ACCESSWIRE / November 13, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial...